Penumbra, Inc. (PEN) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Alameda, CA, United States. The current CEO is Adam Elsesser.
PEN has IPO date of 2015-09-18, 4,500 full-time employees, listed on the NYSE, a market capitalization of $13.04B.
Penumbra, Inc. is a medical device company headquartered in Alameda, California, that designs, develops, manufactures, and markets innovative vascular intervention and neurosurgical products globally. The company specializes in aspiration-based thrombectomy systems for mechanical clot removal, neurovascular embolization coiling systems for treating aneurysms, and neurovascular access systems, marketed under brands including Penumbra System, Penumbra Coil, and Neuron. Its product portfolio also encompasses neurosurgical aspiration tools, peripheral embolization devices, microcatheters, and occlusion devices, along with immersive technology solutions for patient rehabilitation. Penumbra distributes its products through direct sales teams and distributor networks to serve the interventional neuroradiology, neurosurgery, and vascular surgery markets worldwide.
